1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The site of visceral metastases (mets) to predict overall survival (OS) in castration-resistant prostate cancer (CRPC) patients (pts): A meta-analysis of five phase III trials
    Meeting Abstract

    Halabi, S.; Kelly, W. K.; Zhou, H. J.; Armstrong, A. J.; Quinn, D.; Fizazi, K.; Solomon, N. C.; Tannock, I.; Petrylak, D. P.; Morris, M. J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Effect of enzalutamide (Enza) on androgen receptor (AR) positive (+) ovarian cancer
    Meeting Abstract

    Grisham, R. N.; Thapi, D.; Berman, T.; de Stanchina, E.; Zhou, Q.; Iasonos, A.; Iyer, G.; Aghajanian, C.; Spriggs, D. R.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Comparative effectiveness of gemcitabine plus cisplatin (GC) versus methotrexate, vinblastine, doxorubicin, plus cisplatin (MVAC) as neoadjuvant therapy for muscle-invasive bladder cancer (MIBC)
    Meeting Abstract

    Galsky, M. D.; Harshman, L. C.; Crabb, S. J.; Wong, Y. N.; Yu, E. Y.; Chowdhury, S.; Powles, T.; Pal, S. K.; Moshier, E. L.; Ladoire, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase II trial of temsirolimus plus low-dose weekly carboplatin and paclitaxel for recurrent/metastatic HNSCC
    Meeting Abstract

    Fury, M. G.; Xiao, H.; Baxi, S. S.; Sherman, E. J.; Smith-Marrone, S.; Ho, A. L.; Sima, C. S.; Nwankwo, O. G.; Haque, S.; Katabi, N.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Pathologic correlation of 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Feldman, J. L.; Fox, J. J.; Martinez, D. F.; Autio, K. A.; Durack, J. C.; Humm, J.; Schoder, H.; Gavane, S. C.; Curtis, K. R.; Balakirsky, S. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Acute changes in endothelial function with cisplatin among germ cell tumor (GCT) patients (Pts)
    Meeting Abstract

    Feldman, D. R.; Jacobsen, E. P.; Woo, K.; Steingart, R.; Fleisher, M.; Patil, S.; Carousso, M.; Laguerre, S.; Morales, T. D.; Sheinfeld, J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Genotype correlations with blood pressure and efficacy outcomes from the randomized phase III AXIS trial of secondline axitinib versus sorafenib in metastatic renal cell carcinoma
    Meeting Abstract

    Escudier, B. J.; Rini, B. I.; Motzer, R. J.; Tarazi, J. C.; Kim, S.; Huang, X.; Rosbrook, B.; English, P. A.; Loomis, A. K.; Williams, J. A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Molecular characterization of circulating tumor cells (CTC) and CTC subpopulations in baseline and progressive metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Dittamore, R.; Louw, J.; Krupa, R.; Danila, D. C.; Arslan, Z.; Schreiber, N. A.; Bales, N.; Marrinucci, D.; Scher, H. I.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase 3, randomized, placebo-controlled trial of orteronel (TAK-700) plus prednisone in patients (pts) with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC) (ELM-PC 4 trial)
    Meeting Abstract

    De Wit, R.; Fizazi, K.; Jinga, V.; Efstathiou, E.; Fong, P. C. C.; Wirth, M.; Suzuki, K.; Moran, S.; Wang, L.; Akaza, H.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase I study of DSTP3086S, an antibody-drug conjugate (ADC) targeting STEAP-1, in patients (pts) with metastatic castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Szmulewitz, R. Z.; Baron, A. D.; Higano, C. S.; Scher, H. I.; Morris, M. J.; Gilbert, H.; Brunstein, F.; Lemahieu, V.; Kabbarah, O.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save